We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > GBG

News List

Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions contractpharma
March 05, 2021
Genesis Biotechnology Group (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development (GD3) have acquired the Berkeley-based CRO Integrated Analytical Solutions (IAS).
Genesis Biotechnology Acquires STATKING Clinical Services contractpharma
January 07, 2021
Genesis Biotechnology Group (GBG) and its CRO arm Genesis Drug Discovery & Development (GD3), has acquired the STATKING Clinical Services, a provider of clinical trial services, including clinical trial management, protocol development, biostatistics ...
IBRANCE (palbociclib) fails trial for early breast cancer treatment expresspharma
October 10, 2020
No unexpected safety signals were observed and it did not meet improved invasive disease-free survival in women with HR+, HER2- early breast cancer in the PENELOPE-B trial.
GBG & Yale Partner for Drug Discovery contractpharma
November 01, 2018
GBG & Yale Partner for Drug Discovery